» Articles » PMID: 38995503

Recent Advances in Nanomaterials for the Treatment of Femoral Head Necrosis

Overview
Journal Hum Cell
Publisher Springer
Specialty Cell Biology
Date 2024 Jul 12
PMID 38995503
Authors
Affiliations
Soon will be listed here.
Abstract

Osteonecrosis of the femoral head (ONFH) is a condition that causes considerable pain and discomfort for patients, and its pathogenic mechanisms are not yet fully understood. While there have been many studies that suggest multiple factors may contribute to its development, current treatments involve both surgical and nonsurgical options. However, there is still much room for improvement in these treatment methods, particularly when it comes to preventing postoperative complications and optimizing surgical procedures. Nanomaterials, as a type of small molecule material, have shown great promise in treating bone tissue diseases, including ONFH. In fact, several nanocomposite materials have demonstrated specific effects in preventing ONFH, promoting bone tissue repair and growth, and optimizing surgical treatment. This article provides a comprehensive overview of current treatments for ONFH, including their advantages and limitations, and reviews the latest advances in nanomaterials for treating this condition. Additionally, this article explores the therapeutic mechanisms involved in using nanomaterials to treat ONFH and to identify new methods and ideas for improving outcomes for patients.

References
1.
Zhao D, Zhang F, Wang B, Liu B, Li L, Kim S . Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults (2019 version). J Orthop Translat. 2020; 21:100-110. PMC: 7152793. DOI: 10.1016/j.jot.2019.12.004. View

2.
Hines J, Jo W, Cui Q, Mont M, Koo K, Cheng E . Osteonecrosis of the Femoral Head: an Updated Review of ARCO on Pathogenesis, Staging and Treatment. J Korean Med Sci. 2021; 36(24):e177. PMC: 8216992. DOI: 10.3346/jkms.2021.36.e177. View

3.
Ohnaka K, Taniguchi H, Kawate H, Nawata H, Takayanagi R . Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: novel mechanism of glucocorticoid-induced osteoporosis. Biochem Biophys Res Commun. 2004; 318(1):259-64. DOI: 10.1016/j.bbrc.2004.04.025. View

4.
Yu H, Zhu D, Liu P, Yang Q, Gao J, Huang Y . Osthole stimulates bone formation, drives vascularization and retards adipogenesis to alleviate alcohol-induced osteonecrosis of the femoral head. J Cell Mol Med. 2020; 24(8):4439-4451. PMC: 7176840. DOI: 10.1111/jcmm.15103. View

5.
Ng T, Ji J, Liu Q, Yao Y, Wang W, Cao Y . Evaluation of Myocilin Variant Protein Structures Modeled by AlphaFold2. Biomolecules. 2024; 14(1). PMC: 10813463. DOI: 10.3390/biom14010014. View